Thammasat University Hospital and Novo Nordisk Thailand announced collaboration to enhance holistic approach to obesity and diabetes care

Thammasat University Hospital, in collaboration with Novo Nordisk Pharma (Thailand) Ltd. (“Novo Nordisk”), announced a collaboration titled “Partnership Project for the Transition into the Fourth Decade of Thammasat University Hospital: Beat Obesity Beat Diabetes” at the Thammasat University Hospital. The public-private partnership aims to enhance holistic patient care and expand equitable access for all.

In Thailand, it is estimated that over 40 percent of Thai individuals are classified as overweight or obese 1 . According to the International Diabetes Federation, there are at least 6.4 million people living with diabetes in Thailand 2 . The two non-communicable diseases (NCDs) pose not only a significant public health challenge but also a growing economic concern, leading to reduced productivity, rising healthcare expenditures, and long-term strain on Thailand’s development.

This partnership represents a powerful alliance between Thammasat University Hospital and Novo Nordisk, both of which share the same vision of a holistic approach, focusing on more than just treating diseases and ensuring that everyone has access to the necessary treatment.

Associate Professor Dr Dilok Piyayotai, Director of Thammasat University Hospital, highlighted that “as Thammasat University Hospital is moving towards its fourth decade, our vision is to provide holistic care. We believe that everyone should have equitable access to care and that this collaboration is a stepping stone towards achieving that vision.”

Mr Enrico Cañal Bruland, General Manager of Novo Nordisk, expressed his views on the project, stating, "we are excited to collaborate with a prestigious medical institution with a deep understanding of the Thai healthcare system, like Thammasat University Hospital. This partnership allows us to co-develop an effective and sustainable solution for treating obesity and diabetes"

At the heart of this collaboration lies a digital technology designed to promote two-way communication between patients and healthcare providers. Individuals living with obesity and diabetes can access reliable and easily understandable information, empowering them to take ownership of their health management.